Related references
Note: Only part of the references are listed.A new-generation N/L-type calcium channel blocker leads to less activation of the renin-angiotensin system compared with conventional L type calcium channel blocker
Tadashi Konoshita et al.
JOURNAL OF HYPERTENSION (2010)
Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the life study
Borge G. Nordestgaard et al.
PHARMACOGENETICS AND GENOMICS (2010)
Genetic Variant of the Renin-Angiotensin System and Diabetes Influences Blood Pressure Response to Angiotensin Receptor Blockers
Tadashi Konoshita et al.
DIABETES CARE (2009)
Adenine/cytosine1166 polymorphism of the angiotensin II type 1 receptor gene and the antihypertensive response to angiotensin-converting enzyme inhibitors
Huimin Yu et al.
JOURNAL OF HYPERTENSION (2009)
ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathy
Hans-Henrik Parving et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Clinical variables, not RAAS polymorphisms, predict blood pressure response to ACE inhibitors in Sardinians
Fabiana Filigheddu et al.
PHARMACOGENOMICS (2008)
A proximal direct repeat motif characterized as a negative regulatory element in the human renin gene
Tadashi Konoshita et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Polymorphisms of ACE2 gene are associated with essential hypertension and antihypertensive effects of captopril in women
X. Fan et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Factors influencing blood pressure response to trandolapril add-on therapy in patients taking verapamil SR (from the International Verapamil SR/Trandolapril [INVEST] study)
Martin Brunner et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Synergistic expression of angiotensin-converting enzyme (ACE) and ACE2 in human renal tissue and confounding effects of hypertension on the ACE to ACE2 ratio
Shigeyuki Wakahara et al.
ENDOCRINOLOGY (2007)
Association between angiotensinogen, angiotensin II receptor genes, and blood pressure response to an angiotensin-converting enzyme inhibitor
Xiaowen Su et al.
CIRCULATION (2007)
Exploring design-related bias in clinical studies on receptor genetic polymorphism of hypertension
Pendar Farahani et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2007)
Feasibility of treating prehypertension with an angiotensin-receptor blocker
S Julius et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy
T Konoshita et al.
DIABETES CARE (2006)
T1198C polymorphism of the angiotensinogen gene and antihypertensive response to angiotensin-converting enzyme inhibitors
HM Yu et al.
HYPERTENSION RESEARCH (2005)
Pharmacogenetic association of the angiotensin-converting enzyme insertion/deletion polymorphism on blood pressure and cardiovascular risk in relation to antihypertensive treatment - The genetics of hypertension-associated treatment (GenHAT) study
DK Arnett et al.
CIRCULATION (2005)
The cardiovascular continuum and renin-angiotensin-aldosterone system blockade
V Dzau
JOURNAL OF HYPERTENSION (2005)
Renin-angiotensin system gene polymorphisms: relationship with blood pressure and microalbuminuria in telmisartan-treated hypertensive patients
J Redon et al.
PHARMACOGENOMICS JOURNAL (2005)
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
S Julius et al.
LANCET (2004)
Candidate cis-elements for human renin gene expression in the promoter region
T Konoshita et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Relationship between polymorphism of the angiotensin-converting enzyme gene and the response to angiotensin-converting enzyme inhibition in hypertensive patients
HM Yu et al.
HYPERTENSION RESEARCH (2003)
Functionality of two new polymorphisms in the human renin gene enhancer region
S Fuchs et al.
JOURNAL OF HYPERTENSION (2002)
Angiotensin-converting enzyme 2 - A new cardiac regulator
M Boehm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Expression of renin in large arteries outside the kidney revealed by human renin promoter/LacZ transgenic mouse
S Fuchs et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
B Dahlöf et al.
LANCET (2002)
Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients
L Kurland et al.
JOURNAL OF HYPERTENSION (2001)
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
BM Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
EJ Lewis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
HH Parving et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Effect of ACE gene polymorphism on age at renal death in polycystic kidney disease in Japan
T Konoshita et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2001)
Share Paper
